240 related articles for article (PubMed ID: 26214469)
21. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S
Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464
[TBL] [Abstract][Full Text] [Related]
22. Preleukemic TEL-AML1-positive clones at cell level of 10(-3) to 10(-4) do not persist into adulthood.
Olsen M; Madsen HO; Hjalgrim H; Gregers J; Rostgaard K; Schmiegelow K
J Pediatr Hematol Oncol; 2006 Nov; 28(11):734-40. PubMed ID: 17114960
[TBL] [Abstract][Full Text] [Related]
23. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
[TBL] [Abstract][Full Text] [Related]
24. Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia.
Gandemer V; Rio AG; de Tayrac M; Sibut V; Mottier S; Ly Sunnaram B; Henry C; Monnier A; Berthou C; Le Gall E; Le Treut A; Schmitt C; Le Gall JY; Mosser J; Galibert MD
BMC Genomics; 2007 Oct; 8():385. PubMed ID: 17956600
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization of TEL/AML1 fusion protein in the regulation of human CR1 gene promoter.
Song H; Kim JH; Rho JK; Park SY; Kim CG; Choe SY
Mol Cells; 1999 Oct; 9(5):560-3. PubMed ID: 10597047
[TBL] [Abstract][Full Text] [Related]
26. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
[TBL] [Abstract][Full Text] [Related]
27. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
Peter A; Heiden T; Taube T; Körner G; Seeger K
Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
[TBL] [Abstract][Full Text] [Related]
28. Childhood leukemia genetic bottleneck phenomenon related to TEL-AML1: the postulation by a mathematical model.
Ivanovski P; Ivanovski I; Nikolić D; Jovanović I
Chin Med J (Engl); 2012 Mar; 125(6):1182-5. PubMed ID: 22613552
[TBL] [Abstract][Full Text] [Related]
29. [Study of TEL-AML1 fusion gene in childhood B-lineage acute lymphoblastic leukemia].
Niu C; Huang W; Su X
Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):61-4. PubMed ID: 11601199
[TBL] [Abstract][Full Text] [Related]
30. Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemia.
Kustanovich AM; Belevtsev MV; Stasevich IV; Savitskaya TV; Jutzkevich RI; Savva NN; Aleinikova OV
Leukemia; 2006 Jan; 20(1):165-7. PubMed ID: 16307024
[No Abstract] [Full Text] [Related]
31. Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia.
Uckun FM; Pallisgaard N; Hokland P; Navara C; Narla R; Gaynon PS; Sather H; Heerema N
Leuk Lymphoma; 2001 Jun; 42(1-2):41-56. PubMed ID: 11699220
[TBL] [Abstract][Full Text] [Related]
32. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
Schmidt K; Seeger K; Scheibenbogen C; Bender R; Abdulla M; Süssmilch S; Salama A; Moldenhauer A
J Leukoc Biol; 2009 Mar; 85(3):563-73. PubMed ID: 19129484
[TBL] [Abstract][Full Text] [Related]
34. Revealing the role of TEL/AML1 for leukemic cell survival by RNAi-mediated silencing.
Zaliova M; Madzo J; Cario G; Trka J
Leukemia; 2011 Feb; 25(2):313-20. PubMed ID: 21109770
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of the efficacy of two chemotherapy protocols for children with TEL-AML1[STBZ] fusion gene positive acute lymphoblastic leukemia].
Wang KL; Mei YY; Cui L; Gao C; Liu FF; Zhao XX; Li WJ; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Wu MY; Zhou X; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):285-90. PubMed ID: 24762993
[TBL] [Abstract][Full Text] [Related]
36. The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells.
Ford AM; Palmi C; Bueno C; Hong D; Cardus P; Knight D; Cazzaniga G; Enver T; Greaves M
J Clin Invest; 2009 Apr; 119(4):826-36. PubMed ID: 19287094
[TBL] [Abstract][Full Text] [Related]
37. AML1 gene over-expression in childhood acute lymphoblastic leukemia.
Mikhail FM; Serry KA; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Coignet L; Nucifora G
Leukemia; 2002 Apr; 16(4):658-68. PubMed ID: 11960347
[TBL] [Abstract][Full Text] [Related]
38. Late ovarian relapse of TEL/AML1 positive ALL confirming that TEL deletion is a secondary event in leukemogenesis.
Ly-Sunnaram B; Henry C; Gandemer V; Mee FL; Burtin F; Blayau M; Cayuela JM; Oster M; Clech P; Rambeau M; Marie C; Pampin C; Edan C; Gall EL; Goasguen JE
Leuk Res; 2005 Sep; 29(9):1089-94. PubMed ID: 16038737
[TBL] [Abstract][Full Text] [Related]
39. Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome.
Stams WA; Beverloo HB; den Boer ML; de Menezes RX; Stigter RL; van Drunen E; Ramakers-van-Woerden NL; Loonen AH; van Wering ER; Janka-Schaub GE; Pieters R
Leukemia; 2006 Mar; 20(3):410-6. PubMed ID: 16424874
[TBL] [Abstract][Full Text] [Related]
40. CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: proposal for an accelerated diagnostic flowchart.
Gandemer V; Aubry M; Roussel M; Rio AG; de Tayrac M; Vallee A; Mosser J; Ly-Sunnaram B; Galibert MD
Leuk Res; 2010 Apr; 34(4):430-7. PubMed ID: 19896186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
